ECOG-ACRIN EAY131-I

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol I: EAY131-I: GDC-0032 (taselisib) in Patients with Tumors (other than breast cancer) with PIK3CA mutation but without KRAS mutation or PTEN loss

 

(See required screening study ECOG-ACRIN EAY131)

NCT#02465060

Effective immediately, 06/15/18, EAY131-I is formally closed to accrual, as it has reached its enrollment goal.